PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma

Yco,Lisette  P.; Geerts,Dirk; Koster,Jan; Bachmann,André  S.

doi:10.3892/ijo.2013.1836

PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma

Authors:
- Lisette P. Yco
- Dirk Geerts
- Jan Koster
- André S. Bachmann
View Affiliations

Affiliations: Department of Pharmaceutical Sciences, College of Pharmacy, University of Hawaii at Hilo, Hilo, HI 96720, USA, Department of Human Genetics, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
Published online on: February 21, 2013 https://doi.org/10.3892/ijo.2013.1836
Pages: 1408-1416

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prenylated Rab acceptor 1 domain family, member 2 (PRAF2) is a novel 19-kDa protein with four transmembrane-spanning domains that belongs to the PRAF protein family. Neuroblastoma (NB) is the most common malignant extracranial solid tumor of childhood that originates in primitive cells of the developing sympathetic nervous system. We investigated the correlation of PRAF2 mRNA expression to NB clinical and genetic parameters using Affymetrix expression analysis of a series of 88 NB tumors and examined the functional role of PRAF2 in an NB cell line using RNA interference. We found that high PRAF2 expression is significantly correlated to several unfavorable NB characteristics: MYCN amplification, high age at diagnosis, poor outcome and high INSS stage. The shRNA-mediated PRAF2 downregulation in the SK-N-SH NB cell line resulted in decreased cellular proliferation, migration and matrix-attachment. These findings were confirmed in NB patient tumor samples, where high PRAF2 expression is significantly correlated to bone and bone marrow metastasis, the main cause of death in NB patients. The present study shows that PRAF2 plays an essential role in NB tumorigenesis and metastasis.

View Figures

View References

1	Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003. View Article : Google Scholar : PubMed/NCBI
2	Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
3	Schweneker M, Bachmann AS and Moelling K: JM4 is a four-transmembrane protein binding to the CCR5 receptor. FEBS Lett. 579:1751–1758. 2005. View Article : Google Scholar : PubMed/NCBI
4	Fo CS, Coleman CS, Wallick CJ, Vine AL and Bachmann AS: Genomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2). Gene. 371:154–165. 2006. View Article : Google Scholar : PubMed/NCBI
5	Bachmann AS, Duennebier FF and Mocz G: Genomic organization, characterization, and molecular 3D model of GDE1, a novel mammalian glycerophosphoinositol phosphodiesterase. Gene. 371:144–153. 2006. View Article : Google Scholar
6	Koomoa DL, Go RC, Wester K and Bachmann AS: Expression profile of PRAF2 in the human brain and enrichment in synaptic vesicles. Neurosci Lett. 436:171–176. 2008. View Article : Google Scholar : PubMed/NCBI
7	Borsics T, Lundberg E, Geerts D, et al: Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: influence on cell survival and migration. Cancer Sci. 101:1624–1631. 2010. View Article : Google Scholar : PubMed/NCBI
8	Sivars U, Aivazian D and Pfeffer SR: Yip3 catalyses the dissociation of endosomal Rab-GDI complexes. Nature. 425:856–859. 2003. View Article : Google Scholar : PubMed/NCBI
9	Compton SL and Behrend EN: PRAF1: a Golgi complex trans-membrane protein that interacts with viruses. Biochem Cell Biol. 84:940–948. 2006. View Article : Google Scholar : PubMed/NCBI
10	Compton SL, Kemppainen RJ and Behrend EN: Prenylated Rab acceptor domain family member 1 is involved in stimulated ACTH secretion and inhibition. Cell Signal. 21:1901–1909. 2009. View Article : Google Scholar : PubMed/NCBI
11	Kim JT, Cho MY, Choi SC, et al: Prenylated Rab acceptor 1 (PRA1) inhibits TCF/beta-catenin signaling by binding to beta-catenin. Biochem Biophys Res Commun. 349:200–208. 2006. View Article : Google Scholar : PubMed/NCBI
12	Li LY, Shih HM, Liu MY and Chen JY: The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction. J Biol Chem. 276:27354–27362. 2001. View Article : Google Scholar : PubMed/NCBI
13	Liu HP, Wu CC and Chang YS: PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1. EMBO J. 25:4120–4130. 2006. View Article : Google Scholar : PubMed/NCBI
14	Lin CI, Orlov I, Ruggiero AM, et al: Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3–18. Nature. 410:84–88. 2001.
15	Mao WG, Liu ZL, Chen R, Li AP and Zhou JW: JWA is required for the antiproliferative and pro-apoptotic effects of all-trans retinoic acid in HeLa cells. Clin Exp Pharmacol Physiol. 33:816–824. 2006. View Article : Google Scholar : PubMed/NCBI
16	Chen H, Bai J, Ye J, et al: JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. Cell Signal. 19:1315–1327. 2007. View Article : Google Scholar : PubMed/NCBI
17	Geerts D, Wallick CJ, Koomoa DL, et al: Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation. Clin Cancer Res. 13:6312–6319. 2007. View Article : Google Scholar
18	Valster A, Tran NL, Nakada M, Berens ME, Chan AY and Symons M: Cell migration and invasion assays. Methods. 37:208–215. 2005. View Article : Google Scholar : PubMed/NCBI
19	Fardin P, Barla A, Mosci S, et al: A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Mol Cancer. 9:1852010. View Article : Google Scholar : PubMed/NCBI
20	Revet I, Huizenga G, Chan A, et al: The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma. Exp Cell Res. 314:707–719. 2008. View Article : Google Scholar : PubMed/NCBI
21	Barrett T, Troup DB, Wilhite SE, et al: NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res. 37:D885–D890. 2009. View Article : Google Scholar : PubMed/NCBI
22	Bewick V, Cheek L and Ball J: Statistics review 12: survival analysis. Crit Care. 8:389–394. 2004. View Article : Google Scholar : PubMed/NCBI
23	Vento MT, Zazzu V, Loffreda A, et al: Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cell. PLoS One. 5:e156362010. View Article : Google Scholar : PubMed/NCBI
24	Malumbres M and Barbacid M: Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9:153–166. 2009. View Article : Google Scholar : PubMed/NCBI
25	Molenaar JJ, Koster J, Ebus ME, et al: Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis. Genes Chromosomes Cancer. 51:10–19. 2012. View Article : Google Scholar : PubMed/NCBI
26	Bai J, Zhang J, Wu J, et al: JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling. Oncogene. 29:1227–1237. 2010. View Article : Google Scholar : PubMed/NCBI
27	Hynes RO: Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants - or both? Cell. 113:821–823. 2003. View Article : Google Scholar : PubMed/NCBI
28	Hendrix A, Westbroek W, Bracke M and De Wever O: An ex(o) citing machinery for invasive tumor growth. Cancer Res. 70:9533–9537. 2010. View Article : Google Scholar : PubMed/NCBI
29	Peinado H, Lavotshkin S and Lyden D: The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 21:139–146. 2011. View Article : Google Scholar : PubMed/NCBI
30	Shi GZ, Yuan Y, Jiang GJ, et al: PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma. BMC Cancer. 12:972012. View Article : Google Scholar : PubMed/NCBI